Low awareness of kidney disease remains a challenge for clinical trial recruitment

Novel inherited variants may raise risk for Hodgkin lymphoma
30 September 2022
A new urine test could help curtail the use of the latest synthetic cannabinoids to enter the drug scene
30 September 2022

Low awareness of kidney disease remains a challenge for clinical trial recruitment

Among 80 participants of the NKF Patient Network, a national U.S. kidney disease registry, 60% were not aware of their kidney function level.

Comments are closed.